RXRX Recursion Pharmaceuticals, Inc.
Healthcare$3.01-3.22%ClosedMarket Cap: $1.35B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$8.25
Target (Median)
$8.25
Target Range
$5.50 - $11.00
Upside from current price: 174.1%
Rating Distribution
2 Strong Buy1 Buy5 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-05-07 | Needham | maintain | Buy | Buy |
| 2026-04-30 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-02-26 | B of A Securities | maintain | Neutral | Neutral |
| 2025-12-17 | JP Morgan | upgrade | Overweight | Neutral |
| 2025-09-11 | Needham | maintain | Buy | Buy |
| 2025-07-08 | Needham | maintain | Buy | Buy |
| 2025-06-16 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.92 | $61.2M | 6 |
| Fri Dec 31 | $-0.87 | $111.5M | 6 |
| Sun Dec 31 | $-0.76 | $153.7M | 1 |
| Mon Dec 31 | $-0.94 | $247.5M | 1 |